Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Evogene Ltd. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- 0 vs. Q1 2025
- Shares held
- 130.4K
- −290.9K (−69.0%) vs. Q1 2025
- Total value
- $166.9K
- −$360.0K (−68.3%) vs. Q1 2025
- New holders
- 4
- 5 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $120.0K |
| Q1 2026 | 15 | $408.9K |
| Q4 2025 | 18 | $199.8K |
| Q3 2025 | 14 | $176.1K |
| Q2 2025 | 16 | $166.9K |
| Q1 2025 | 16 | $526.9K |
| Q4 2024 | 15 | $751.6K |
| Q3 2024 | 14 | $1.70M |
| Q2 2024 | 28 | $2.55M |
| Q1 2024 | 29 | $3.04M |
| Q4 2023 | 33 | $3.69M |
| Q3 2023 | 35 | $2.73M |
| Q2 2023 | 28 | $759.5K |
| Q1 2023 | 27 | $500.6K |
| Q4 2022 | 31 | $753.9K |
| Q3 2022 | 26 | $1.21M |
| Q2 2022 | 29 | $1.25M |
| Q1 2022 | 38 | $3.18M |
| Q4 2021 | 43 | $10.0M |
| Q3 2021 | 39 | $16.7M |
| Q2 2021 | 44 | $25.3M |
| Q1 2021 | 46 | $42.1M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Evogene Ltd.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 42 | $0 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 15 | $19 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 190 | $244 | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 200 | $256 | 0.00% | +200 | New |
| Tradewinds Capital Management, LLC | 300 | $384 | 0.00% | +300 | New |
| Federation des caisses Desjardins du Quebec | 500 | $640 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 505 | $646 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 669 | $856 | 0.00% | +597+829.2% | Added |
| Bank of America Corp | 2,471 | $3.16K | 0.00% | +2,387+2,841.7% | Added |
| UBS Group AG | 6,729 | $8.61K | 0.00% | −12,016−64.1% | Reduced |
| BNP Paribas Arbitrage, SA | 14,119 | $18.1K | 0.00% | +1,300+10.1% | Added |
| Jane Street Group, LLC | 15,023 | $19.2K | 0.00% | −18,709−55.5% | Reduced |
| Morgan Stanley | 15,186 | $19.4K | 0.00% | +600+4.1% | Added |
| Two Sigma Securities, LLC | 21,089 | $27.0K | 0.00% | +7,527+55.5% | Added |
| Citadel Advisors LLC | 21,369 | $27.4K | 0.00% | +21,369 | New |
| Virtu Financial LLC | 32,017 | $41.0K | 0.00% | +32,017 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −316,024−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,179−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Tidemark, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |